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Conclusions. RA shows an increased capacity for producing radioinduced damage, and thus a paradoxical damaging effect, in
melanoma cells. Potentially, research into substances like RA could help to clarify mechanisms that may provide protection to
healthy normal cells while exclusively damaging neoplastic cell, thus presenting a new strategy for cancer patients undergoing
radiotherapy.
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Introduction. Breast cancer is a leading death cause among 30 and 50 years old women from industrialized countries and distal
metastases after treatment are the main responsible of this high death rate. Ionizing radiation (IR) along with chemotherapy
has traditionally been used as ﬁrst-line therapy against breast cancer. Protocol optimization led us to improve clinical breast
cancer outcome. However, during the last decade, some epidemiological and translational studies have been pointing out some
tumour-promoting properties in those cells that survive after radiation exposure. Matrix metalloproteinases (MMPs) have been
proposed as one of the main candidates to enrol this effect since MMPs have been described as chief proteases involved in stromal
ﬁbre turnover.
Hypothesis. The purpose of this study was to evaluate in vitro the MMP contribution to second malignancies arising after breast
radiotherapy (RT) and to demonstrate whether this effect might be epigenetically softened.
Materials and methods. Two breast cancer cell lines MDA-MB-231 and MCF-7 were cultured in DMEM supplemented with 10%
FBS. Radiation-derived MMP levels were measured by both real-time PCR and WesternBlot. Gelatinolytic activity was detected by
confocal microscopy and an ELISA-like assay using DQ gelatin. Invasion capability after radiation was also quantiﬁed.
Results. Our results revealed that MDA-MB-231 signiﬁcantly enhanced invasion capability after IR exposure. Gene and protein
expression analyses revealed increased amounts of MMP-1 (collagenase), MMP-3 (stromelysin) and both TIMP-1 and TIMP-2
(tissue inhibitors/activators of MMPs) after irradiation. MMP activity (measured by the amount of cleavage gelatine) was also
increased in this breast cancer cell line. In order to soften this radiation-induced MMP activity, the histone deacethylator inhibitor
valproic acid (VA) was tested. Our ﬁndings reﬂect that VA reduces both IR-enhanced MMP gene expression and activity. Moreover,
our data conﬁrm a dose-dependent radiosensitizing effect of VA.
Conclusions. Taken together, our results suggest that VA might be considered a potential adjuvant enhancer of breast radiotherapy
effectiveness. Our data reveal that VA not only is able to radiosensitize breast tumour cells but also to reduce RT-derived tumour-
promoting effects.
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Introduction. Although radiotherapy approach has improved local control and survival rates with acceptable toxicity, recurrence
is essentially seen in most patients and some of them develop radioresistance that might limit any further treatment. Stem-
like cells (SLCs) isolation from breast tumors has allowed the analysis of the molecular mechanism involved in their origin,
self-renewal, differentiation into tumor cells, resistance to radio and chemotherapy, and invasiveness and metastatic ability.
Hypothesis. The purpose of this work was to evaluate the role of SLCs in breast cancer response to radiotherapy. We have studied
the inﬂuence of ionizing radiation (IR) exposure in tumor SLCs enrichment and whether this subpopulation contributes to tumor
radioresistance. Evaluation of IR-induced tumor-promoting properties in those SLCs has also been carried out.
Materials and methods. Two breast cancer cell lines (MCF-7 and MDA-MB-231) and SLCs, sorted by ﬂow cytometry from those cell
cultures, were grown at 37 ◦C and 5% CO2 in DMEM supplemented with 10% FBS and stem cell culture medium, respectively. Cells
were irradiated 24h after seeding and harvested 24h later. Radiation-induced invasiveness-related matrix metalloproteinases
